MSCI vs PRCT · P/E 37, rev $1.72B vs rev $177.6M
MSCI Inc (MSCI) versus Procept Biorobotics Corp (PRCT) — a side-by-side from cached financials, not a winner call.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
Latest reported MSCI revenue for 2026-06-30 was $1.72B. Net income was $748.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Latest reported PRCT revenue for 2026-06-30 was $177.6M. Net income was -$58.5M. PRCT currently screens at market cap $1.52B.
MSCI currently screens at market cap $46.82B and trailing P/E 36.8. PRCT currently screens at market cap $1.52B.
Not investment advice. Open the MSCI and PRCT stock pages for the full models.
Not investment advice.